BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22949781)

  • 1. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of ICD shock burden by eliminating back-up pacing induced ventricular tachyarrhythmias.
    Theis C; Mollnau H; Sonnenschein S; Konrad T; Himmrich E; Bock K; Schulz E; Kämpfner D; Gerhardt S; Quesada Ocete B; Münzel T; Rostock T
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):889-895. PubMed ID: 24654876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
    Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB
    J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator.
    Strickberger SA; Canby R; Cooper J; Coppess M; Doshi R; John R; Connolly AT; Roberts G; Karst E; Daoud EG
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):416-422. PubMed ID: 28128491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG; Stanton MS; Benditt DG; Trusty J; Collins J
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of antitachycardia pacing alerts for the reduction of emergency presentations following shocks in patients with implantable cardioverter-defibrillators: implications for the implementation of remote monitoring.
    Boulé S; Ninni S; Finat L; Botcherby EJ; Kouakam C; Klug D; Marquié C; Brigadeau F; Lacroix D; Kacet S; Guédon-Moreau L
    Europace; 2016 Dec; 18(12):1809-1817. PubMed ID: 26711741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias.
    Ricci R; Pignalberi C; Disertori M; Capucci A; Padeletti L; Botto G; Toscano S; Miraglia F; Grammatico A; Santini M
    Eur Heart J; 2002 Sep; 23(18):1471-9. PubMed ID: 12208228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator shock: appropriate or inappropriate?
    Nault MA; McIntyre WF; Simpson CS; Redfearn DP; Abdollah H; Brennan FJ; Baranchuk A
    Ann Noninvasive Electrocardiol; 2010 Apr; 15(2):181-3. PubMed ID: 20522060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators.
    Porterfield JG; Porterfield LM; Smith BA; Bray L; Voshage L; Martinez A
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):170-3. PubMed ID: 7681566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intrinsic antitachycardia pacing for ventricular tachycardia refractory to conventional burst pacing: A case series.
    Kamakura T; Ueda N; Wada M; Ishibashi K; Kusano K
    J Cardiovasc Electrophysiol; 2023 Jan; 34(1):225-228. PubMed ID: 36511471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninety-six episodes of spontaneous ventricular tachycardia in 1 week: success of ramp pacing by a pacer-cardioverter-defibrillator.
    Porterfield JG; Porterfield LM; Bray L
    Pacing Clin Electrophysiol; 1991 Oct; 14(10):1440-3. PubMed ID: 1721122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of antitachycardia pacemaker and automatic implantable cardioverter/defibrillator for ventricular tachycardia.
    Manz M; Gerckens U; Funke HD; Kirchhoff PG; Lüderitz B
    Pacing Clin Electrophysiol; 1986 Sep; 9(5):676-84. PubMed ID: 2429273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.